Amoxicillin-Clavulanate
Cross-source consensus on Amoxicillin-Clavulanate from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Comparisons
Evidence quality
Highlighted claims
- WHO and AWaRe guidance identify amoxicillin-clavulanate as a second-choice option for bacterial CAP. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis
- The review included 17 amoxicillin-clavulanate trials with 5,432 patients. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis
- All amoxicillin-clavulanate trials reported clinical resolution as their primary outcome. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis
- Amoxicillin-clavulanate showed no clear evidence of different clinical resolution compared with other antibiotics. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis
- A later trial found intravenous amoxicillin-clavulanate was non-inferior to ampicillin-sulbactam in adult CAP. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis